Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,460.00p

Change Today:

-248.00p
52 Week High: 15,316.00p
52 Week Low: 10,956.00p

Currency: UK Pounds
Shares Issued: 1,551.03m
Volume: 3,963,823

Market Cap: £177,748m
RiskGrade: 123
Beta: 0.00

Latest ShareCast News

AstraZeneca, Bristol Myers Squibb in talks over $400bn tie-up - report

By Michele Maatouk

Date: Monday 03 Aug 2026

(Sharecast News) - AstraZeneca is reportedly in talks to combine with US rival Bristol Myers Squibb in a deal that would create one of the world's biggest pharmaceutical groups, valued at nearly $400bn.

Read full story

News Channel

AstraZeneca reports first-half growth, disappointment in Ultomiris trial

By Josh White

Date: Monday 27 Jul 2026

(Sharecast News) - AstraZeneca reported first-half total revenue of $30.7bn on Monday, up 9%, while core earnings per share increased 12% to $5.21 as double-digit growth in its Oncology and Rare Disease businesses offset headwinds from Farxiga's US loss of exclusivity and China's volume-based procurement programme.

Read full story

News Channel

AstraZeneca breast cancer drug receives EU approval

By Abigail Townsend

Date: Thursday 23 Jul 2026

(Sharecast News) - A breast cancer drug developed by AstraZeneca has been approved in the European Union for the treatment of certain types of the disease, the pharmaceutical giant announced on Thursday.

Read full story

News Channel

Astrazeneca strikes exclusive licensing deal wit...	14-Jul-2026	ShareCast
AstraZeneca shares slide on failure of cardiomyo...	09-Jul-2026	ShareCast
AstraZeneca's Datroway and Enhertu candidates re...	29-Jun-2026	ShareCast
Astrazeneca secures US approval for Truqap combo...	15-Jun-2026	ShareCast
Astrazeneca's Imfinzi receives green light from ...	29-May-2026	ShareCast
US FDA pushes back decision on Astrazeneca's cam...	27-May-2026	ShareCast
Astrazeneca's Camizestrant cleared in the EU, En...	26-May-2026	ShareCast
Citi sees buying opportunity at AstraZeneca afte...	18-May-2026	ShareCast
AstraZeneca secures US approval for two drugs	18-May-2026	ShareCast
AstraZeneca reports positive results from bladde...	14-May-2026	ShareCast
London close: Stocks mixed as investors mull lon...	01-May-2026	ShareCast
AstraZeneca Q1 revenues grow, reiterates FY26 co...	29-Apr-2026	ShareCast
AstraZeneca's asthma maintenance treatment recei...	28-Apr-2026	ShareCast
AstraZeneca's Saphnelo Pen gets green light from...	27-Apr-2026	ShareCast
AstraZeneca receives positive high level results...	21-Apr-2026	ShareCast
AstraZeneca reports positive top-line data from ...	20-Apr-2026	ShareCast
AstraZeneca's COPD candidate succeeds in twin Ph...	27-Mar-2026	ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

AstraZeneca Market Data

Currency	UK Pounds
Share Price	11,460.00p
Change Today	-248.00p
% Change	-2.12 %
52 Week High	15,316.00p
52 Week Low	10,956.00p
Volume	3,963,823
Shares Issued	1,551.03m
Market Cap	£177,748m
Beta	0.00
RiskGrade	123